Seth van Voorhees - 25 Nov 2022 Form 4/A - Amendment Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Seth Van Voorhees
Issuer symbol
NRXP
Transactions as of
25 Nov 2022
Net transactions value
+$18,215
Form type
4/A - Amendment
Filing time
19 Dec 2022, 06:08:15 UTC
Date Of Original Report
28 Nov 2022
Previous filing
29 Jun 2022
Next filing
19 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock, par value $0.001 per share Purchase $9,762 +8,716 $1.12 8,716 25 Nov 2022 Direct F1
transaction NRXP Common Stock, par value $0.001 per share Purchase $660 +600 +6.9% $1.10 9,316 25 Nov 2022 Direct F2
transaction NRXP Common Stock, par value $0.001 per share Purchase $7,793 +7,021 +75% $1.11 16,337 25 Nov 2022 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.
F2 The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.
F3 Total number of shares held is reduced by 40 shares to correct an arithmetic error in the original Form 4.
F4 The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.